As per market analysts, the global market is anticipated to witness growth owing to the factors such as massive geriatric population as well as surge in product launches. However, the market will face challenges and restraints due to product callbacks and quality related concerns during the forecast period 2023 to 2032. 

 

Intensification in unhealthy lifestyle choices in the market is set to play a key role in determining the growth potential during 2023 to 2032years. Analysts have also studied the market to understand potential threats and challenges the market companies could face. Although the market is poised to grow at a fast pace across treatment type and end-user segments, factors such as the amplified product recalls could slow down the market's growth worldwide.

 

Market Segmentation 

 

The market has been segmented into treatment type and end-user. Based on the segment which is  treatment type, the peripheral artery disease market is categorized on the basis of devices (angioplasty balloon, angioplasty stents (stenting), catheters, hemodynamic flow alteration devices, plaque modification devices (atherectomy), and others), drugs (blood clot preventing drugs, blood pressure lowering drugs, glucose regulating drugs, lipid-lowering drugs). The global market for peripheral artery disease is further segmented based on end-user into ambulatory surgery centers, hospitals and clinics, and others. 

 

The global market research report covers all the aspects of the market based on the segmental analysis of these treatment type and end-user segments. Analysts have also studied the global market's regional markets spread across many continents and countries. The treatment type and end-user segments along with their sub-segments have been analyzed and companies functioning in the market across these segments are profiled and analyzed based on input and feedback from market based decision makers as well as primary and secondary sources. The peripheral artery disease market research report presents analysis based information for companies functioning in the market. 

 

Regional Overview 

 

The growing incidents of product recall may hinder the peripheral artery disease market growth. The market research report suggests that companies in the market could be supported by broadening insurance coverage as well as the expansion in insurance coverage during the forecast period. The market is set to register growth at a high CAGR owing to these key factors. The market is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global market research report reveals that APAC, North America, and Europe regional markets will dominate the global market for peripheral artery disease during the forecast period 2019 to 2025. As per market analysts, the market is set to witness tremendous growth across devices as well as hospitals and clinics segments in North America which covers markets across the United States, Canada, Mexico and several other regional markets. Companies active in the market are also analyzed and studied in the peripheral artery disease market research report.

 

The peripheral artery disease market for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the market research report covers the Asia-Pacific region covering markets from India, China, Japan, Australia, and others. The market is also spread across the rest of the world. The market report covers all such regions including the Middle East, Africa, Brazil, and others. 

 

Competitive Landscape 

 

Peripheral artery disease has seen increased demand over the years, due to the commonness of unhealthy eating habits and lifestyles revolving around sedentary work. Companies functioning in the global market are also being challenged due to quality issues and unfavorable regulations. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period 2019 to 2025. As the market is set to register a high CAGR of 4.84% and is also anticipated to reach a US$23,624.01 million by 2025, the report highlights key areas companies need to focus on. The report suggests that the peripheral artery disease market will see a healthy growth in the long run till 2025. Based on SWOT analysis and market’s analysis based on Porters’ Five Force Model presented in the market report. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period 2019 to 2025.  

 

Industry News 

 

Royal Philips revealed today that it has decided to buy Intact Vascular for $275 million in cash up front. Intact Vascular, headquartered in Wayne, Pennsylvania, manufactures the Tack, a customised implantable system for managing peripheral arterial disease (PAD). As a new, limited, dissection repair platform for treating peripheral vascular reconstructions during angioplasty interventions, the Tack interventional system confirms normal and medication balloon PAD care outcomes.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Peripheral artery disease Market Research Report